Screener
The Clorox Company CLX Ratios & Valuation
| Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 42.3%-2.9pp | 43.8%-1.4pp | 44.2%-0.4pp | 44.3%-0.2pp | 45.2%+2.3pp | |
| Net margin | 8.7%-2.7pp | 11.2%+1.3pp | 11.2%+4.8pp | 11.7%+6.9pp | 11.4%+7.5pp | |
| Returns | ||||||
| Return on equity | 285.6%+36.0pp | —— | —— | —— | 249.6%+147pp | |
| Return on invested capital | 18.6%-10.5pp | 28.3%+0.8pp | 30%+11.0pp | 31.5%+15.3pp | 29.1%+16.9pp | |
| Efficiency | ||||||
| Asset turnover | 1×-0.2× | 1.1×-0.1× | 1.2×0.0× | 1.2×-0.1× | 1.3×0.0× | |
| Liquidity | ||||||
| Current ratio | 0.7×-0.2× | 0.8×+0.1× | 0.7×-0.2× | 0.8×-0.2× | 0.8×-0.2× | |
| Leverage | ||||||
| Debt-to-equity | 50.1×+41.1× | —— | —— | —— | 9.1×+0.1× | |
| Net debt / EBITDA | 3.7×+1.8× | 2.5×+0.3× | 2.3×-0.6× | 2.2×-0.8× | 2×-1.8× | |
| Per Share | ||||||
| Book value per share | $0.74-71.5% | -$0.55-353% | -$1.03-212% | -$0.18-137% | $2.58-1.7% | |
| Valuation | ||||||
| Market capitalization | $9.8B-34.8% | $12.53B-30.9% | $12.3B-38.8% | $15.08B-25.3% | $15.04B-11.3% | |
| Price / earnings | 16.7×-2.3× | 16.6×-9.6× | 16.3×-27.7× | 19.1×-37.5× | 18.6×-42.0× | |
| Price / sales | 1.5×-0.8× | 1.9×-0.7× | 1.8×-1.0× | 2.2×-0.5× | 2.1×-0.3× | |
| Price / book | 108.4×— | —— | —— | —— | 46.9×-4.8× | |
| EV / EBITDA | 12.1×-1.5× | 12.1×-4.6× | 11.7×-12.2× | 13.6×-12.7× | 12.8×-14.4× | |
| Dividend yield | 6.2%+2.1pp | 4.8%+1.5pp | 4.9%+1.9pp | 4%+1.0pp | 4%+0.5pp |
FAQ
- Where do The Clorox Company's ratios come from?
- Every ratio is computed from The Clorox Company's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
